Virtu Financial LLC boosted its stake in Opko Health Inc. (NASDAQ:OPK) by 313.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 278,680 shares of the biotechnology company’s stock after purchasing an additional 211,209 shares during the quarter. Virtu Financial LLC’s holdings in Opko Health were worth $1,366,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. State Street Corp grew its holdings in Opko Health by 3.9% in the second quarter. State Street Corp now owns 11,348,763 shares of the biotechnology company’s stock worth $74,671,000 after purchasing an additional 422,203 shares during the period. Dimensional Fund Advisors LP grew its holdings in Opko Health by 127.2% in the third quarter. Dimensional Fund Advisors LP now owns 4,003,643 shares of the biotechnology company’s stock worth $27,466,000 after purchasing an additional 2,241,103 shares during the period. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Opko Health by 83.7% in the third quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,579,950 shares of the biotechnology company’s stock worth $17,698,000 after purchasing an additional 1,175,726 shares during the period. IFP Advisors Inc grew its holdings in Opko Health by 37.1% in the fourth quarter. IFP Advisors Inc now owns 1,963,601 shares of the biotechnology company’s stock worth $9,622,000 after purchasing an additional 531,088 shares during the period. Finally, Schwab Charles Investment Management Inc. grew its holdings in Opko Health by 43.0% in the third quarter. Schwab Charles Investment Management Inc. now owns 1,566,433 shares of the biotechnology company’s stock worth $10,746,000 after purchasing an additional 471,256 shares during the period. Institutional investors and hedge funds own 22.22% of the company’s stock.
Opko Health Inc. (NASDAQ:OPK) opened at $3.57 on Thursday. Opko Health Inc. has a 12 month low of $3.56 and a 12 month high of $8.69. The firm has a market cap of $2,064.20, a price-to-earnings ratio of -16.23 and a beta of 1.42. The company has a quick ratio of 1.48, a current ratio of 1.66 and a debt-to-equity ratio of 0.01.
In other Opko Health news, CEO Phillip Md Et Al Frost acquired 100,000 shares of the company’s stock in a transaction on Wednesday, January 24th. The shares were purchased at an average cost of $4.89 per share, with a total value of $489,000.00. Following the completion of the purchase, the chief executive officer now owns 3,068,951 shares of the company’s stock, valued at $15,007,170.39. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders acquired 860,500 shares of company stock worth $3,596,435 over the last ninety days. Insiders own 40.19% of the company’s stock.
OPK has been the topic of a number of recent research reports. BidaskClub lowered shares of Opko Health from a “sell” rating to a “strong sell” rating in a research note on Wednesday, January 10th. Zacks Investment Research lowered shares of Opko Health from a “hold” rating to a “sell” rating in a research note on Thursday, January 11th. Finally, Cantor Fitzgerald set a $20.00 price objective on shares of Opko Health and gave the company a “buy” rating in a research note on Wednesday, October 25th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the stock. Opko Health has a consensus rating of “Hold” and an average target price of $13.34.
ILLEGAL ACTIVITY NOTICE: This news story was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/22/virtu-financial-llc-boosts-holdings-in-opko-health-inc-opk.html.
About Opko Health
OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.
Want to see what other hedge funds are holding OPK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Opko Health Inc. (NASDAQ:OPK).
Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.